|
Name: Ethchlorvynol
Type: Sedative
AKA: Placidyl
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Ethchlorvynol, introduced in the 1950s, is a sedative and hypnotic medication. It was used for its calming effects but has largely been replaced by newer medications due to concerns about side effects and addiction.
|
|
V. Legal Information
Ethchlorvynol, a barbiturate derivative used for sedation, is classified as a controlled substance due to its potential for abuse. Its status reflects regulations aimed at managing its use and preventing misuse.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Ethchlorvynol is a sedative used for its calming effects. As a downer, it promotes relaxation and sleep. Short-term effects include reduced anxiety and improved sleep quality, while long-term use is generally safe with minimal risks. Overdose risks involve excessive sedation and potential respiratory issues. Safe dosing is typically guided by a healthcare provider. Recent research focuses on its effectiveness for sleep and anxiety management.  |
|
VII. Psychological Effects
Ethchlorvynol, a sedative-hypnotic, impacts GABA-A receptors, leading to sedation and cognitive impairment. Immediate effects include relaxation and reduced anxiety, with long-term use potentially causing dependence and cognitive decline. Research indicates risks of psychological dependence and mood disturbances with chronic use.
 |
|
VIII. Culture
Ethchlorvynol is a sedative and hypnotic, classifying it as a downer. Short-term use induces sedation and sleep, while long-term use can lead to dependence, tolerance, and cognitive impairment. Overdose risks include severe sedation, respiratory depression, and potentially fatal outcomes. Safe dosages are typically prescribed by medical professionals. Recent research highlights its effectiveness in inducing sleep but warns of high dependence and overdose risks. Physical effects include drowsiness, impaired coordination, and potential respiratory depression.
 |